Malinverno Luca, Barros Vesna, Ghisoni Francesco, Visonà Giovanni, Kern Roman, Nickel Philip J, Ventura Barbara Elvira, Šimić Ilija, Stryeck Sarah, Manni Francesca, Ferri Cesar, Jean-Quartier Claire, Genga Laura, Schweikert Gabriele, Lovrić Mario, Rosen-Zvi Michal
Porini SRL, Via Cavour, 222074 Lomazzo, Italy.
AI for Accelerated Healthcare & Life Sciences Discovery, IBM R&D Laboratories, University of Haifa Campus, Mount Carmel, Haifa 3498825, Israel.
Patterns (N Y). 2023 Sep 8;4(9):100830. doi: 10.1016/j.patter.2023.100830.
The black-box nature of most artificial intelligence (AI) models encourages the development of explainability methods to engender trust into the AI decision-making process. Such methods can be broadly categorized into two main types: post hoc explanations and inherently interpretable algorithms. We aimed at analyzing the possible associations between COVID-19 and the push of explainable AI (XAI) to the forefront of biomedical research. We automatically extracted from the PubMed database biomedical XAI studies related to concepts of causality or explainability and manually labeled 1,603 papers with respect to XAI categories. To compare the trends pre- and post-COVID-19, we fit a change point detection model and evaluated significant changes in publication rates. We show that the advent of COVID-19 in the beginning of 2020 could be the driving factor behind an increased focus concerning XAI, playing a crucial role in accelerating an already evolving trend. Finally, we present a discussion with future societal use and impact of XAI technologies and potential future directions for those who pursue fostering clinical trust with interpretable machine learning models.
Patterns (N Y). 2023-9-8
J Med Internet Res. 2024-12-24
Diagnostics (Basel). 2022-1-19
Chem Biol Drug Des. 2023-7
Brief Bioinform. 2023-9-20
Pharmaceuticals (Basel). 2025-1-3
NPJ Digit Med. 2024-12-27
PLOS Digit Health. 2023-2-9
Comput Methods Programs Biomed. 2022-11
R Soc Open Sci. 2022-8-3
Nat Commun. 2022-7-27
Proc IEEE Int Symp Biomed Imaging. 2021-4
Nat Rev Drug Discov. 2022-3
Nat Med. 2022-1